Systemic sclerosis in the time of COVID-19
Anna‐Maria Hoffmann‐Vold, Oliver Distler, Cosimo Bruni, Christopher P. Denton, Jeska de Vries‐Bouwstra, Marco Matucci‐Cerinic, Madelon C Vonk, Armando Gabrielli
Topics & Concepts
MedicineRituximabMultiple sclerosisCoronavirus disease 2019 (COVID-19)PandemicVaccinationDiseasePopulationIntensive care medicineImmunologyInternal medicineAntibodyInfectious disease (medical specialty)Environmental healthSystemic Sclerosis and Related DiseasesDermatological and COVID-19 studiesDiagnosis and Treatment of Venous Diseases